Page last updated: 2024-10-18

iodine and Weight Gain

iodine has been researched along with Weight Gain in 29 studies

Iodine: A nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90. It is a nutritionally essential element, especially important in thyroid hormone synthesis. In solution, it has anti-infective properties and is used topically.
diiodine : Molecule comprising two covalently bonded iodine atoms with overall zero charge..

Weight Gain: Increase in BODY WEIGHT over existing weight.

Research Excerpts

ExcerptRelevanceReference
"A farm trial was conducted to evaluate the effect of in-water iodine on piglet growth, the incidence of diarrhea, and the development of deleterious oral and dental conditions."9.15Effect of in-water iodine supplementation on weight gain, diarrhea and oral and dental health of nursery pigs. ( Cassar, G; Farzan, A; Friendship, RM; Tucker, AL, 2011)
"The impact of excessive iodine intake on the development of autoimmune thyroiditis (AIT) is still under debate."7.80Enhanced iodine supplementation alters the immune process in a transgenic mouse model for autoimmune thyroiditis. ( Allelein, S; Bernecker, C; Domröse, A; Ehlers, M; Feldkamp, J; Haase, M; Papewalis, C; Schinner, S; Schott, M; Stenzel, W; Thiel, A; Willenberg, HS, 2014)
"We investigated the combined roles of a low-nutrition diet (low levels of protein, iodine, and selenium) and T-2 toxin in bone development and to establish an experimental animal model of Kashin-Beck disease (KBD) that reliably mimics the disease's pathological changes for further study of the pathogenesis and prevention of the disease."7.79An animal model of Kashin-Beck disease induced by a low-nutrition diet and exposure to T-2 toxin. ( Kang, P; Pei, F; Shen, B; Yang, J; Yao, Y; Zhou, Z, 2013)
"A farm trial was conducted to evaluate the effect of in-water iodine on piglet growth, the incidence of diarrhea, and the development of deleterious oral and dental conditions."5.15Effect of in-water iodine supplementation on weight gain, diarrhea and oral and dental health of nursery pigs. ( Cassar, G; Farzan, A; Friendship, RM; Tucker, AL, 2011)
"The impact of excessive iodine intake on the development of autoimmune thyroiditis (AIT) is still under debate."3.80Enhanced iodine supplementation alters the immune process in a transgenic mouse model for autoimmune thyroiditis. ( Allelein, S; Bernecker, C; Domröse, A; Ehlers, M; Feldkamp, J; Haase, M; Papewalis, C; Schinner, S; Schott, M; Stenzel, W; Thiel, A; Willenberg, HS, 2014)
"We investigated the combined roles of a low-nutrition diet (low levels of protein, iodine, and selenium) and T-2 toxin in bone development and to establish an experimental animal model of Kashin-Beck disease (KBD) that reliably mimics the disease's pathological changes for further study of the pathogenesis and prevention of the disease."3.79An animal model of Kashin-Beck disease induced by a low-nutrition diet and exposure to T-2 toxin. ( Kang, P; Pei, F; Shen, B; Yang, J; Yao, Y; Zhou, Z, 2013)
"Iodine concentration was determined in thyroid gland, liver, kidney, muscle, fat, and skin by ICP-MS."2.77Effect of iodine source and dose on growth and iodine content in tissue and plasma thyroid hormones in fattening pigs. ( Hammerl, S; Li, Q; Mair, C; Schedle, K; Schodl, K; Windisch, W, 2012)
"Iodine was determined in the thyroid and in the fractions innards/blood, bones and muscle/fat of four pigs of each group by ICP-MS."1.35Influence of dietary iodine on the iodine content of pork and the distribution of the trace element in the body. ( Berk, A; Flachowsky, G; Franke, K; Leiterer, M; Schöne, F, 2008)
"Ractopamine was fed at the level of 10 mg/kg (as-fed basis) of feed."1.33Effects of different cereal grains and ractopamine hydrochloride on performance, carcass characteristics, and fat quality in late-finishing pigs. ( Baker, DH; Carr, SN; Ellis, M; Killefer, J; McKeith, FK; Rincker, PJ, 2005)
" Higher iodine dosage increased the serum T4 concentration of pigs receiving 75 g rapeseed press cake per kg diet (= 1."1.31Effects of rapeseed-press cake glucosinolates and iodine on the performance, the thyroid gland and the liver vitamin A status of pigs. ( Bargholz, J; Hartung, H; Leiterer, M; Schöne, F; Tischendorf, F, 2001)
"Iodine deficiency was evidenced by increased thyroid weight (26%), reduced urinary iodine excretion (80%), and reduced plasma T4 concentrations (22%)."1.29Thyroid function and deiodinase activities in rats with marginal iodine deficiency. ( Beynen, AC; Janssen, KP; Kaptein, E; Van Der Heide, D; Visser, TJ, 1994)
"Since hypothyroidism has definite and substantial morbidity, these results are of importance to public health and medical personnel for a Bayesian approach to the aetiological diagnosis of hypothyroidism and for ordering specific confirmatory laboratory investigations."1.28Aetiological profile of overt hypothyroidism in Indian population. ( Agarwal, SK; Jangid, DR; Jangid, V; Ram, BK, 1991)
" The 2/3 lower glucosinolate dosage of the LGRSM diet also decreased performance and provoked I deficiency, however significantly later."1.28[Testing in swine of meal extracted from winter rapeseed with different glucosinolate content with regard to iodine supply. 1. Characterization of rapeseed extraction particles and fattening results]. ( Brautzsch, R; Hennig, A; Lange, R; Lüdke, H; Schöne, F, 1990)

Research

Studies (29)

TimeframeStudies, this research(%)All Research%
pre-19901 (3.45)18.7374
1990's10 (34.48)18.2507
2000's4 (13.79)29.6817
2010's14 (48.28)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McGovern, FM1
Sweeney, T1
Ryan, MT1
Lott, S1
Campion, FP1
Boland, TM1
Kang, P1
Yao, Y1
Yang, J2
Shen, B2
Zhou, Z1
Pei, F1
Ehlers, M1
Thiel, A1
Papewalis, C1
Domröse, A1
Stenzel, W1
Bernecker, C1
Haase, M1
Allelein, S1
Schinner, S1
Willenberg, HS1
Feldkamp, J1
Schott, M1
Malek, L1
Makrides, M1
Zhao, LN1
Xu, J1
Peng, XL1
Tian, LY1
Hao, LP1
Yang, XF1
Ying, CJ1
Sun, XF1
Soriguer, F1
Valdes, S1
Morcillo, S1
Esteva, I1
Almaraz, MC1
de Adana, MS1
Tapia, MJ1
Dominguez, M1
Gutierrez-Repiso, C1
Rubio-Martin, E1
Garrido-Sanchez, L1
Perez, V1
Garriga, MJ1
Rojo-Martinez, G1
Garcia-Fuentes, E1
Eversmann, T1
Li, Q1
Mair, C1
Schedle, K1
Hammerl, S1
Schodl, K1
Windisch, W1
Yao, YF1
Pei, FX1
Li, XB1
Zhou, ZK1
Li, L1
Kang, PD1
Tucker, AL1
Farzan, A1
Cassar, G1
Friendship, RM1
Gewa, CA1
Leslie, TF1
Pawloski, LR1
Schöne, F3
Tischendorf, F1
Leiterer, M2
Hartung, H1
Bargholz, J2
NORDSIEK, FW1
Carr, SN1
Rincker, PJ1
Killefer, J1
Baker, DH1
Ellis, M1
McKeith, FK1
Wongsuthavas, S1
Terapuntuwat, S1
Wongsrikeaw, W1
Katawatin, S1
Yuangklang, C1
Beynen, AC2
Franke, K1
Berk, A1
Flachowsky, G1
Comby, F1
Lagorce, JF1
Buxeraud, J1
Raby, C1
Janssen, KP1
Van Der Heide, D1
Visser, TJ1
Kaptein, E1
Allen, LH1
Richter, G1
Lemser, A1
Wichtel, JJ1
Craigie, AL1
Freeman, DA1
Varela-Alvarez, H1
Williamson, NB1
Elnour, A1
Liedén, S1
Bourdoux, P1
Eltom, M1
Khalid, SA1
Hambraeus, L1
Paik, IK1
Jangid, DR1
Agarwal, SK1
Jangid, V1
Ram, BK1
Lange, R1
Lüdke, H1
Brautzsch, R1
Hennig, A1
Jenkins, KJ1
Hidiroglou, M1
Rosenfeld, M1
Cunningham, S1
Harris, WT1
Lapey, A1
Regelmann, WE1
Sawicki, GS1
Southern, KW1
Chilvers, M1
Higgins, M1
Tian, S1
Cooke, J1
Davies, JC1
Seliger, VI1
Rodman, D1
Van Goor, F1
Schmelz, A1
Mueller, P1
Konstan, MW1
Plant, BJ1
Elborn, JS1
Rodriguez, S1
Munck, A1
Ahrens, R1
Johnson, C1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Phase 3, 2-Arm, Roll-Over Study to Evaluate the Long-term Safety and Pharmacodynamics of Ivacaftor Treatment in Pediatric Subjects With Cystic Fibrosis and a CFTR Gating Mutation[NCT01946412]Phase 333 participants (Actual)Interventional2013-12-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Absolute Change From Baseline of Parent Study in Body Mass Index (BMI) at Week 12, 24, 36, 48, 60, 72 and 84

BMI = (Weight [in kg]) divided by (Stature [in meters]) ^2. Baseline was defined as the most recent measurement prior to intake of the first dose of study drug in study 108 Part B (NCT01705145). (NCT01946412)
Timeframe: Baseline (study 108), Week 12, 24, 36, 48, 60, 72 and 84 (study 109)

,
InterventionKilogram per square meter (kg/m^2) (Mean)
Baseline (n=9, 24)Absolute Change at Week 12 (n=9, 23)Absolute Change at Week 24 (n=9, 23)Absolute Change at Week 36 (n=9, 23)Absolute Change at Week 48 (n=9, 22)Absolute Change at Week 60 (n=9, 22)Absolute Change at Week 72 (n=9, 20)Absolute Change at Week 84 (n=9, 19)
Ivacaftor 50 mg15.740.030.310.15-0.31-0.12-0.38-0.16
Ivacaftor 75 mg16.060.09-0.120.09-0.13-0.060.090.28

Absolute Change From Baseline of Parent Study in Stature at Week 12, 24, 36, 48, 60, 72 and 84

Stature was measured as height if children could stand unassisted and follow directions; otherwise, stature was measured as length. Baseline was defined as the most recent measurement prior to intake of the first dose of study drug in study 108 Part B (NCT01705145). (NCT01946412)
Timeframe: Baseline (study 108), Week 12, 24, 36, 48, 60, 72 and 84 (study 109)

,
InterventionCentimeters (cm) (Mean)
Baseline (n=9, 24)Absolute Change in Week 12 (n=9, 23)Absolute Change in Week 24 (n=9, 23)Absolute Change in Week 36 (n=9, 23)Absolute Change in Week 48 (n=9, 21)Absolute Change in Week 60 (n=9, 22)Absolute Change in Week 72 (n=9, 20)Absolute Change in Week 84 (n=9, 19)
Ivacaftor 50 mg89.14.66.07.89.711.012.513.6
Ivacaftor 75 mg102.35.47.78.810.411.613.415.0

Absolute Change From Baseline of Parent Study in Sweat Chloride at Week 24, 48, 72 and 84

Sweat samples were collected using an approved Macroduct (Wescor, Logan, Utah) collection device. A volume of greater than or equal to (>=) 15 microliter was required for determination of sweat chloride. Baseline was defined as the most recent measurement prior to intake of the first dose of study drug in study 108 Part B (NCT01705145). (NCT01946412)
Timeframe: Baseline (study 108), Week 24, 48, 72 and 84 (study 109)

,
Interventionmillimole per liter (mmol/L) (Mean)
Baseline (n=7,22)Absolute Change at Week 24 (n=6,18)Absolute Change at Week 48 (n=6,15)Absolute Change at Week 72 (n=7,14)Absolute Change at Week 84 (n=6,14)
Ivacaftor 50 mg93.1-62.1-29.3-46.4-46.5
Ivacaftor 75 mg99.6-48.5-51.8-52.9-58.1

Absolute Change From Baseline of Parent Study in Weight at Week 12, 24, 36, 48, 60, 72 and 84

Baseline was defined as the most recent measurement prior to intake of the first dose of study drug in study 108 Part B (NCT01705145) (NCT01946412)
Timeframe: Baseline (study 108), Week 12, 24, 36, 48, 60, 72 and 84 (study 109)

,
Interventionkilogram (kg) (Mean)
Baseline (n=9, 24)Absolute Change at Week 12 (n= 9, 23)Absolute Change at Week 24 (n=9, 23)Absolute Change at Week 36 (n=9, 23)Absolute Change at Week 48 (n=9, 22)Absolute Change at Week 60 (n=9, 22)Absolute Change at Week 72 (n=9, 20)Absolute Change at Week 84 (n=9, 19)
Ivacaftor 50 mg12.51.32.02.42.63.23.44.0
Ivacaftor 75 mg16.81.92.53.13.44.04.85.7

Absolute Change From Baseline of Study 109 in Body Mass Index (BMI) at Week 12, 24, 36, 48, 60, 72 and 84

BMI = (Weight [in kg]) divided by (Stature [in meters]) ^2. Baseline is defined as the most recent measurement prior to intake of the first dose of study drug in study 109 (NCT01946412). (NCT01946412)
Timeframe: Baseline (study 109), Week 12, 24, 36, 48, 60, 72 and 84 (study 109)

,
Interventionkg/m^2 (Mean)
Baseline (n= 9, 24)Absolute Change at Week 12 (n= 9, 23)Absolute Change at Week 24 (n= 9, 23)Absolute Change at Week 36 (n= 9, 23)Absolute Change at Week 48 (n= 9, 22)Absolute Change at Week 60 (n= 9, 22)Absolute Change at Week 72 (n= 9, 20)Absolute Change at Week 84 (n= 9, 19)
Ivacaftor 50 mg16.07-0.30-0.02-0.18-0.64-0.45-0.71-0.49
Ivacaftor 75 mg16.33-0.16-0.36-0.16-0.35-0.29-0.21-0.01

Absolute Change From Baseline of Study 109 in Stature at Week 12, 24, 36, 48, 60, 72 and 84

Stature was measured as height if children could stand unassisted and follow directions; otherwise, stature was measured as length. Baseline is defined as the most recent measurement prior to intake of the first dose of study drug in study 109 (NCT01946412). (NCT01946412)
Timeframe: Baseline (study 109), Week 12, 24, 36, 48, 60, 72 and 84 (study 109)

,
Interventioncm (Mean)
Baseline (n=9, 24)Absolute Change at Week 12 (n=9, 23)Absolute Change at Week 24 (n=9, 23)Absolute Change at Week 36 (n=9, 23)Absolute Change at Week 48 (n=9, 21)Absolute Change at Week 60 (n=9, 22)Absolute Change at Week 72 (n=9, 20)Absolute Change at Week 84 (n=9, 19)
Ivacaftor 50 mg91.72.03.45.27.28.410.011.1
Ivacaftor 75 mg105.81.84.15.26.88.09.811.4

Absolute Change From Baseline of Study 109 in Sweat Chloride at Week 24, 48, 72 and 84

Sweat samples were collected using an approved Macroduct (Wescor, Logan, Utah) collection device. A volume of >=15 microliter was required for determination of sweat chloride. Baseline is defined as the most recent measurement prior to intake of the first dose of study drug in study 109 (NCT01946412). (NCT01946412)
Timeframe: Baseline (study 109), Week 24, 48, 72 and 84 (study 109)

,
Interventionmmol/L (Mean)
Baseline (n= 8,23)Absolute Change at Week 24 (n=7,18)Absolute Change at Week 48 (n=7,17)Absolute Change at Week 72 (n=8,15)Absolute Change at Week 84 (n=7,16)
Ivacaftor 50 mg47.8-4.318.1-1.5-2.4
Ivacaftor 75 mg52.93.4-4.5-6.0-11.2

Absolute Change From Baseline of Study 109 in Weight at Week 12, 24, 36, 48, 60, 72 and 84

Baseline is defined as the most recent measurement prior to intake of the first dose of study drug in study 109 (NCT01946412). (NCT01946412)
Timeframe: Baseline (study 109), Week 12, 24, 36, 48, 60, 72 and 84 (study 109)

,
InterventionKg (Mean)
Baseline (n= 9, 24)Absolute Change at Week 12 (n=9, 23)Absolute Change at Week 24 (n=9, 23)Absolute Change at Week 36 (n=9, 23)Absolute Change at Week 48 (n=9, 22)Absolute Change at Week 60 (n=9, 22)Absolute Change at Week 72 (n=9, 20)Absolute Change at Week 84 (n=9, 19)
Ivacaftor 50 mg13.50.31.01.41.62.22.43.0
Ivacaftor 75 mg18.30.41.01.61.92.53.34.2

Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)

AE: any untoward medical occurrence in a participant during the study; the event does not necessarily have a causal relationship with the treatment. This includes any newly occurring event or previous condition that has increased in severity or frequency after the informed consent form is signed. AE includes serious as well as Non-serious AEs. SAE (subset of AE): medical event or condition, which falls into any of the following categories, regardless of its relationship to the study drug: death, life threatening adverse experience, Inpatient hospitalization/prolongation of hospitalization, persistent/significant disability or incapacity, congenital anomaly/birth defect, important medical event. AEs with start date or increased severity on or after the first dose of study drug through the end of study participation was considered treatment-emergent. (NCT01946412)
Timeframe: Day 1 up to Week 97 (for participants who completed study drug dosing); Day 1 up to 24 weeks after the last dose (up to Week 108, for participants who prematurely discontinued study drug dosing)

,
Interventionparticipants (Number)
AEsSAEs
Ivacaftor 50 mg96
Ivacaftor 75 mg245

Reviews

1 review available for iodine and Weight Gain

ArticleYear
Nutritional influences on linear growth: a general review.
    European journal of clinical nutrition, 1994, Volume: 48 Suppl 1

    Topics: Body Height; Child; Child Nutrition Disorders; Child, Preschool; Copper; Developing Countries; Diet;

1994

Trials

4 trials available for iodine and Weight Gain

ArticleYear
Effect of iodine source and dose on growth and iodine content in tissue and plasma thyroid hormones in fattening pigs.
    European journal of nutrition, 2012, Volume: 51, Issue:6

    Topics: Animal Husbandry; Animals; Austria; Crosses, Genetic; Diet; Energy Intake; Iodates; Iodine; Kidney;

2012
Effect of in-water iodine supplementation on weight gain, diarrhea and oral and dental health of nursery pigs.
    Canadian journal of veterinary research = Revue canadienne de recherche veterinaire, 2011, Volume: 75, Issue:4

    Topics: Animals; Diarrhea; Dietary Supplements; Female; Iodine; Male; Mouth Diseases; Swine; Swine Diseases;

2011
An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2-5 years (KLIMB).
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2019, Volume: 18, Issue:6

    Topics: Aminophenols; Body Mass Index; Child, Preschool; Chloride Channel Agonists; Cystic Fibrosis; Cystic

2019
Efficacy response in CF patients treated with ivacaftor: post-hoc analysis.
    Pediatric pulmonology, 2015, Volume: 50, Issue:5

    Topics: Adolescent; Adult; Aminophenols; Child; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Co

2015

Other Studies

24 other studies available for iodine and Weight Gain

ArticleYear
An investigation into the effects of maternal supplementation with excess iodine on the mechanisms and impacts of reduced IgG absorption in the lamb postpartum.
    The British journal of nutrition, 2017, Volume: 117, Issue:7

    Topics: Animals; Animals, Newborn; beta 2-Microglobulin; Colostrum; Dietary Supplements; Female; Gene Expres

2017
An animal model of Kashin-Beck disease induced by a low-nutrition diet and exposure to T-2 toxin.
    Osteoarthritis and cartilage, 2013, Volume: 21, Issue:8

    Topics: Animal Nutritional Physiological Phenomena; Animals; Cartilage, Articular; Chondrocytes; Dietary Pro

2013
Enhanced iodine supplementation alters the immune process in a transgenic mouse model for autoimmune thyroiditis.
    Thyroid : official journal of the American Thyroid Association, 2014, Volume: 24, Issue:5

    Topics: Animals; CD8-Positive T-Lymphocytes; Cytokines; Dietary Supplements; Female; Immunity, Cellular; Imm

2014
2.8 Nutrition in pregnancy and lactation.
    World review of nutrition and dietetics, 2015, Volume: 113

    Topics: Alcohol Drinking; Body Mass Index; Breast Feeding; Caffeine; Calcium, Dietary; Dairy Products; Diet;

2015
Dose and time-dependent hypercholesterolemic effects of iodine excess via TRbeta1-mediated down regulation of hepatic LDLr gene expression.
    European journal of nutrition, 2010, Volume: 49, Issue:5

    Topics: Animals; Dose-Response Relationship, Drug; Down-Regulation; Drinking; Eating; Female; Hypercholester

2010
Thyroid hormone levels predict the change in body weight: a prospective study.
    European journal of clinical investigation, 2011, Volume: 41, Issue:11

    Topics: Adiponectin; Adult; Body Weight; Cohort Studies; Female; Follow-Up Studies; Humans; Insulin Resistan

2011
[Hypothyroidism].
    MMW Fortschritte der Medizin, 2011, Mar-03, Volume: 153, Issue:9

    Topics: Aged; Algorithms; Fatigue; Female; Humans; Hypothyroidism; Iodine; Pregnancy; Selenium; Thyroid Func

2011
Preventive effects of supplemental selenium and selenium plus iodine on bone and cartilage development in rats fed with diet from Kashin-Beck disease endemic area.
    Biological trace element research, 2012, Volume: 146, Issue:2

    Topics: Animals; Bone Development; Cartilage; Diet; Dietary Supplements; Drug Synergism; Endemic Diseases; F

2012
Geographic distribution and socio-economic determinants of women's nutritional status in Mali households.
    Public health nutrition, 2013, Volume: 16, Issue:9

    Topics: Adult; Anthropometry; Body Mass Index; Breast Feeding; Catchment Area, Health; Contraceptive Agents;

2013
Effects of rapeseed-press cake glucosinolates and iodine on the performance, the thyroid gland and the liver vitamin A status of pigs.
    Archiv fur Tierernahrung, 2001, Volume: 55, Issue:4

    Topics: Animal Feed; Animals; Brassica rapa; Dose-Response Relationship, Drug; Eating; Glucosinolates; Iodin

2001
A goitrogenic rat diet producing normal body weight gain.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1961, Volume: 108

    Topics: Animals; Body Weight; Diet; Goiter; Ideal Body Weight; Iodine; Nutrition Assessment; Nutritional Sta

1961
Effects of different cereal grains and ractopamine hydrochloride on performance, carcass characteristics, and fat quality in late-finishing pigs.
    Journal of animal science, 2005, Volume: 83, Issue:1

    Topics: Adipose Tissue; Adrenergic beta-Antagonists; Animal Feed; Animals; Body Weight; Diet; Edible Grain;

2005
Influence of amount and type of dietary fat on deposition, adipocyte count and iodine number of abdominal fat in broiler chickens.
    Journal of animal physiology and animal nutrition, 2008, Volume: 92, Issue:1

    Topics: Abdominal Fat; Adipocytes; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Body Co

2008
Influence of dietary iodine on the iodine content of pork and the distribution of the trace element in the body.
    European journal of nutrition, 2008, Volume: 47, Issue:1

    Topics: Analysis of Variance; Animal Feed; Animals; Deficiency Diseases; Dose-Response Relationship, Drug; F

2008
Antithyroid action of ketoconazole: in-vitro studies and rat in-vivo studies.
    The Journal of pharmacy and pharmacology, 1994, Volume: 46, Issue:1

    Topics: Animals; Antithyroid Agents; In Vitro Techniques; Iodine; Ketoconazole; Lactoperoxidase; Male; Methi

1994
Thyroid function and deiodinase activities in rats with marginal iodine deficiency.
    Biological trace element research, 1994, Volume: 40, Issue:3

    Topics: Animals; Brain; Creatinine; Diet; Eating; Iodide Peroxidase; Iodine; Liver; Male; Organ Size; Rats;

1994
[Rapeseed and rapeseed meal as components in diets of laying hens].
    Archiv fur Tierernahrung, 1996, Volume: 49, Issue:3

    Topics: Animal Feed; Animals; Brassica; Chickens; Diet; Eating; Egg Yolk; Eggs; Fatty Acids; Female; Iodine;

1996
Effect of selenium and lodine supplementation on growth rate and on thyroid and somatotropic function in dairy calves at pasture.
    Journal of dairy science, 1996, Volume: 79, Issue:10

    Topics: Animals; Cattle; Female; Growth Hormone; Iodine; Kinetics; Rumen; Selenium; Thyroid Gland; Thyrotrop

1996
Traditional fermentation increases goitrogenic activity in pearl millet.
    Annals of nutrition & metabolism, 1998, Volume: 42, Issue:6

    Topics: Animals; Calcification, Physiologic; Diet; Dietary Proteins; Energy Metabolism; Fermentation; Goiter

1998
Nutritional value of processed rapeseed meal.
    Advances in experimental medicine and biology, 1991, Volume: 289

    Topics: Amino Acids; Ammonia; Animal Feed; Animals; Antithyroid Agents; Brassica; Chickens; Eating; Energy I

1991
Aetiological profile of overt hypothyroidism in Indian population.
    The Journal of the Association of Physicians of India, 1991, Volume: 39, Issue:10

    Topics: Adult; Female; Humans; Hypothyroidism; India; Iodine; Male; Middle Aged; Postoperative Complications

1991
[Testing in swine of meal extracted from winter rapeseed with different glucosinolate content with regard to iodine supply. 1. Characterization of rapeseed extraction particles and fattening results].
    Archiv fur Tierernahrung, 1990, Volume: 40, Issue:9

    Topics: Animal Feed; Animals; Brassica; Eating; Female; Glucosinolates; Glycine max; Iodine; Male; Swine; We

1990
Effects of elevated iodine in milk replacer on calf performance.
    Journal of dairy science, 1990, Volume: 73, Issue:3

    Topics: Animal Feed; Animals; Cattle; Digestion; Eating; Ethylenediamines; Iodine; Male; Thyroid Gland; Tiss

1990
The predictive potential of the sweat chloride test in cystic fibrosis patients with the G551D mutation.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2013, Volume: 12, Issue:6

    Topics: Administration, Oral; Adolescent; Aminophenols; Child; Chlorides; Cystic Fibrosis; Cystic Fibrosis T

2013